Concepedia

Enver Arslantas

EA

3

Publications

60

Citations

3

H-Index

2004

Active since

Affiliations

Eli Lilly (United States)(Current)

Enver Arslantas is an author at Eli Lilly (United States) specializing in natural sciences, chemistry, and medicine.

Top concepts

MedicineChemistryPharmacologyNatural SciencesOrganic ChemistryMedicinal ChemistryBiochemistryDrug DiscoveryDiversity-oriented SynthesisImmunology

Publications per year

2004–2015

3

Publications

3

Synthesis of BACE Inhibitor LY2886721. Part II. Isoxazolidines as Precursors to Chiral Aminothiazines, Selective Peptide Coupling, and a Controlled Reactive Crystallization

Marvin M. Hansen, Daniel J. Jarmer, Enver Arslantas et al. · Organic Process Research & Development · 2015 · 28 citations

Reactive Crystallization, Bioorganic Chemistry, Organic Chemistry +19

TAME‐Hex A − A Novel Bifunctional Chelating Agent for Radioimmunoimaging

Enver Arslantas, Peter Smith‐Jones, Gerd Ritter et al. · European Journal of Organic Chemistry · 2004 · 20 citations

Immunology, Organic Chemistry, Chemistry +20

Synthesis of BACE Inhibitor LY2886721. Part I. An Asymmetric Nitrone Cycloaddition Strategy

Stanley P. Kolis, Marvin M. Hansen, Enver Arslantas et al. · Organic Process Research & Development · 2015 · 12 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Chemistry +15

Rows per page

1–3 of 3